MedPath

The Value of Cardiovascular Imaging in Kawasaki Disease

Conditions
Kawasaki Disease
Registration Number
NCT06641817
Lead Sponsor
West China Second University Hospital
Brief Summary

The goal of this observational study is to assess the cardiovascular injury of Kawasaki disease with multi-modal imaging combined with clinical data.

During their disease progress, participants will undergo cardiovascular magnetic resonance, echocardiography, electrocardiography, laboratory tests, and genetic tests when hospitalization and follow-up, and the baseline data will be collected at the admission. Some patients will undergo coronary computed tomography angiography (CCTA) or DSA due to the disease progress. All the above examination data and changes will be analyzed to assess the value of cardiovascular imaging in the pathogenesis, diagnosis, and prognosis of Kawasaki disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients diagnosed based on the American Heart Association guideline for Kawasaki disease.
Exclusion Criteria
  • Patients with a history of congenital heart disease, cardiomyopathy.
  • Patients with age over 18 years old.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Major adverse cardiovascular events10 years after the onset

Major adverse cardiovascular events including cardiac death, transient ischemic attack or stroke, myocardial infarction, arrhythmia, heart failure, severe valvular disease, percutaneous coronary intervention, coronary artery bypass graft, and other cardiovascular surgery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

West China Second University Hospital, Sichuan University.

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath